Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6373-6380

  Hart, Melanie L ^a   Ceonzo, Kathleen A ^a   Shaffer, Lisa A ^a   Takahashi, Kazue ^b   Rother, Russell P ^c   Reenstra, Wende R ^d   Buras, Jon A ^d   Stahl, Gregory L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ALEXION PHARMACEUTICALS   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; FICOLIN; LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; IMMUNOPATHOGENESIS; INTESTINE ISCHEMIA; LUNG INJURY; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 18644384051     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6373     Document Type: Article

References (55)

1. Tendler, D. A. 2003. Acute intestinal ischemia and infarction. Semin. Gastrointest. Dis. 14: 66-76.
2. Homer-Vanniasinkani, S., J. N. Crinnion, and M. J. Gough. 1997. Post-ischaemic organ dysfunction: a review. Eur. J. Vasc. Endovasc. Surg. 14: 195-203.
3. Carden, D. L., and D. N. Granger. 2000. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190: 255-266.
4. Harward, T. R., D. L. Brooks, T. C. Flynn, and J. M. Seeger. 1993. Multiple organ dysfunction after mesenteric artery revascularization. J. Vasc. Surg. 18: 459-467.
5. Moore, E. E., F. A. Moore, R. J. Franciose, F. J. Kim, W. L. Biffl, and A. Banerjee. 1994. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J. Trauma 37: 881-887.
6. Wada, K., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 120: 126-133.
7. Zhao, H., M. C. Montalto, K. J. Pfeiffer, L. Hao, and G. L. Stahl. 2002. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J. Appl. Physiol. 93: 338-345.
8. Stahl, G. L., Y. Xu, L. Hao, M. Miller, J. A. Buras, M. Fung, and H. Zhao. 2003. Role for the alternative complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162: 449-455.
9. Montalto, M. C., M. L. Hart, J. E. Jordan, K. Wada, and G. L. Stahl. 2003. Role for complement in mediating intestinal nitric oxide synthase-2 and Superoxide dismutase expression. Am. J. Physiol. 285: G197-G206.
10. Poggetti, R. S., F. A. Moore, E. E. Moore, K. Koeike, and A. Banerjee. 1992. Simultaneous liver and lung injury following gut ischemia is mediated by xanthine oxidase. J. Trauma 32: 723-727.
11. Turnage, R. H., K. M. Kadesky, S. I. Myers, K. S. Guice, and K. T. Oldham. 1996. Hepatic hypoperfusion after intestinal reperfusion. Surgery 119: 151-160.
12. Fruchterman, T. M., D. A. Spain, M. A. Wilson, P. D. Harris, and R. N. Garrison. 1998. Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124: 782-791.
13. Williams, J. P., T. T. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore, Jr., M. C. Carroll, and H. B. Hechtman. 1999. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86: 938-942.
14. Karpel-Massler, G., S. D. Fleming, M. Kirschfink, and G. C. Tsokos. 2003. Human C1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury. J. Surg. Res. 115: 247-256.
15. Hart, M. L., M. C. Walsh, and G. L. Stahl. 2004. Initiation of complement activation following oxidative stress: in vitro and in vivo observations. Mol. Immunol. 41: 165-171.
16. Heller, T., M. Hennecke, U. Baumann, J. E. Gessner, A. M. zu Vilsendorf, M. Baensch, F. Boulay, A. Kola, A. Klos, W. Bautsch, et al. 1999. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163: 985-994.
17. Arumugam, T. V., I. A. Shiels, T. M. Woodruff, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2002. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J. Surg. Res. 103: 260-267.
18. Proctor, L. M., T. V. Arumugam, I. Shiels, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2004. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br. J. Pharmacol. 142: 756-764.
19. Reid, R. R., S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen, Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2002. Functional activity of natural antibody is altered in Cr2-deficient mice. J. Immunol. 169: 5433-5440.
20. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169: 2126-2133.
21. Austen, W. G., Jr., L. Kobzik, M. C. Carroll, H. B. Hechtman, and F. D. Moore, Jr. 2003. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int. J. Immunopathol. Pharmacol. 16: 1-8.
22. Zhang, M., W. G. Austen, Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore, Jr., et al. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101: 3886-3891.
23. de Vries, B., S. J. Walter, C. J. Peutz-Kootstra, T. G. Wolfs, L. W. van Heurn, and W. A. Buurman. 2004. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am. J. Pathol. 165: 1677-1688.
24. Jordan, J. E., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104: 1413-1418.
25. Walsh, M. C., T. Bourcier, M. Takahashi, and G. L. Stahl. 2003. Complement activation and tissue injury following myocardial ischemia and reperfusion is C1q independent. Mol. Immunol. 41: 215.
26. Fiane, A. E., V. Videm, P. S. Lingaas, L. Heggelund, E. W. Nielsen, O. R. Geiran, M. Fung, and T. E. Mollnes. 2003. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108: 849-856.
27. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
28. Taylor, P. R., J. T. Nash, E. Theodoridis, A. E. Bygrave, M. J. Walport, and M. Botto. 1998. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem. 273: 1699-1704.
29. Shi, L., K. Takahashi, J. Dundee, S. Shahroor-Kami, S. Thiel, J. C. Jensenius, F. Gad, M. R. Hamblin, K. N. Sastry, and R. A. Ezekowitz. 2004. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J. Exp. Med. 199: 1379-1390.
30. Vakeva, A. P., A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97: 2259-2267.
31. Collard, C. D., A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Meri, and G. L. Stahl. 2000. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156: 1549-1556.
32. Chiu, C. J., A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101: 478-483.
33. Johnson, J., K. L. Brigham, G. Jesmok, and B. Meyrick. 1991. Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor α. Am. Rev. Respir. Dis. 144: 179-186.
34. Collard, C. D., M. C. Montalto, W. R. Reenstra, J. A. Buras, and G. L. Stahl. 2001. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am. J. Pathol. 159: 1045-1054.
35. Bourdi, M., T. P. Reilly, A. G. Elkahloun, J. W. George, and L. R. Pohl. 2002. Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness. Biochem. Biophys. Res. Commun. 294: 225-230.
36. Napolitano, L. M., M. J. Koruda, A. A. Meyer, and C. C. Baker. 1996. The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock 5: 202-207.
37. Suankratay, C., Y. Zhang, D. Jones, T. F. Lint, and H. Gewurz. 1999. Enhancement of lectin pathway haemolysis by immunoglobulins. Clin. Exp. Immunol. 117: 435-441.
38. Zhang, Y., C. Suankratay, X. H. Zhang, T. F. Lint, and H. Gewurz. 1999. Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. Immunopharmacology 42: 81-90.
39. Roos, A., L. H. Bouwman, D. J. Gijlswijk-Janssen, M. C. Faber-Krol, G. L. Stahl, and M. R. Daha. 2001. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167: 2861-2868.
40. Arora, M., E. Munoz, and A. J. Tenner. 2001. Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis. J. Biol. Chem. 276: 43087-43094.
41. Nevens, J. R., A. K. Mallia, M. W. Wendt, and P. K. Smith. 1992. Affinity Chromatographic purification of immunoglobulin M antibodies utilizing immobilized mannan binding protein. J. Chromatogr. 597: 247-256.
42. Bianchino, A. C., P. H. Poon, and V. N. Schumaker. 1988. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor. J. Immunol. 141: 3930-3936.
43. Caliezi, C., W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack. 2000. C1-Esterase inhibitor: an anti-inflammatory agent and ils potential use in the treatment of diseases other than hereditary angioedema. Pharmacol. Rev. 52: 91-112.
44. Matsushita, M., S. Thiel, J. C. Jensenius, I. Terai, and T. Fujita. 2000. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165: 2637-2642.
45. 2-macroglobulin. J. Immunol. 168: 4078-4086.
46. Vajdova, K., R. Smrekova, M. Kukan, M. Lutterova, and L. Wsolova. 2000. Bile analysis as a tool for assessing integrity of biliary epithelial cells after cold ischemia-reperfusion of rat livers. Cryobiology 41: 145-152.
47. Thompson, J. S., L. E. Bragg, and W. W. West. 1990. Serum enzyme levels during intestinal ischemia. Ann. Surg. 211: 369-373.
48. Caglayan, F., O. Caglayan, E. Gunel, Y. Elcuman, and M. Cakmak. 2002. Intestinal ischemia-reperfusion and plasma enzyme levels. Pediatr. Surg. Int. 18: 255-257.
49. Vaughan, W. G., J. W. Horton, and P. B. Walker. 1992. Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. J. Pediatr. Surg. 27: 968-972.
50. Sun, Z., X. Wang, X. Deng, A. Lasson, R. Wallen, E. Hallberg, and R. Andersson, 1998. The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats. Shock 10: 203-207.
51. Nielsen, E. W., T. E. Mollnes, J. M. Harlan, and R. K. Winn. 2002. C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand. J. Immunol. 56: 588-592.
52. Fujita, T., M. Matsushita, and Y. Endo. 2004. The lectin-complement pathway-its role in innate immunity and evolution. Immunol. Rev. 198: 185-202.
53. Akaiwa, M., Y. Yae, R. Sugimoto, S. O. Suzuki, T. Iwaki, K. Izuhara, and N. Hamasaki. 1999. Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J. Histochem. Cytochem. 47: 777-786.
54. Lu, J., and Y. Le. 1998. Ficolins and the fibrinogen-like domain. Immunobiology 199: 190-199.
55. Lynch, N. J., S. Roscher, T. Hartung, S. Morath, M. Matsushita, D. N. Maennel, M. Kuraya, T. Fujita, and W. J. Schwaeble. 2004. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J. Immunol. 172: 1198-1202.